ellipticine has been researched along with 9-hydroxyellipticine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, S; el-Hamouly, W; Modi, SP; Portuese, E; Ruckdeschel, JC | 1 |
| Honda, T; Inoue, M; Kato, M; Nakanishi, T; Noguchi, T; Shima, K; Shimamoto, T; Yoshida, T | 1 |
| Borgna, JL; Delbarre, A; Jacquemin-Sablon, A; Le Pecq, JB; Oberlin, R; Rochefort, H; Roques, BP | 1 |
| Auclair, C; Hyland, K; Paoletti, C | 1 |
| Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
| Auclair, C; Paoletti, C | 1 |
| Acton, EM; Boyd, MR; Narayanan, VL; Risbood, PA; Shoemaker, RH; Vistica, DT | 1 |
| Auclair, C; Dubreuil, P; Le Bret, M; Letard, S; Martin, F; Svinarchuk, F; Vendôme, J | 1 |
| Amorim, RC; Costa, DS; Costa, MR; Eberlin, MN; Grafov, A; Grafova, I; Henrique, MC; Lima, ES; Montoia, A; Pohlit, AM; Rocha E Silva, LF; Souza, RC; Tadei, WP; Torres, ZE; Vasconcellos, MC | 1 |
| Kato, A; Kawagoshi, M; Konakahara, T; Kurasaki, H; Morii, N; Sakai, N; Shimazu, A; Takeda, S | 1 |
| Charcosset, JY; Garbay-Jaureguiberry, C; Jacquemin-Sablon, A; Rigaudy, P; Roques, BP | 1 |
| Auclair, C; Lesca, P; Malvy, C; Paoletti, C; Pinto, M; Tocanne, JF | 1 |
| Nakanishi, N; Ohashi, M; Sugikawa, E | 1 |
| Omar, SI; Tuszynski, J | 1 |
1 review(s) available for ellipticine and 9-hydroxyellipticine
| Article | Year |
|---|---|
Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
Topics: Alkaloids; Animals; Cytochrome P-450 Enzyme System; DNA; Ellipticines; Leukemia L1210; Membrane Lipids; Membranes, Artificial; Mixed Function Oxygenases; Oxidation-Reduction; Phospholipids | 1981 |
13 other study(ies) available for ellipticine and 9-hydroxyellipticine
| Article | Year |
|---|---|
N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbamates; Ellipticines; Humans; Leukemia L1210; Lung Neoplasms; Mice; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
Topics: Alkaloids; Animals; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Ellipticines; Glycosides; Leukemia L1210; Leukemia P388; Melanoma; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Neoplasms, Experimental; Sarcoma 180; Structure-Activity Relationship | 1988 |
Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
Topics: Alkaloids; Animals; Breast Neoplasms; Cattle; Cell Line; DNA; Ellipticines; Female; Humans; In Vitro Techniques; Intercalating Agents; Leukemia L1210; Neoplasms, Hormone-Dependent; Receptors, Estrogen | 1985 |
Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives.
Topics: Alkaloids; Chemical Phenomena; Chemistry; Edetic Acid; Ellipticines; Kinetics; Manganese; Oxidation-Reduction; Oxygen Consumption; Spectrophotometry; Structure-Activity Relationship; Superoxide Dismutase | 1983 |
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |
Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
Topics: Alkaloids; Animals; Antineoplastic Agents; Biotransformation; Ellipticines; Hydrogen Peroxide; Mice; Oxidation-Reduction; Peroxidases; Structure-Activity Relationship | 1981 |
Anticancer specificity of some ellipticinium salts against human brain tumors in vitro.
Topics: Brain Neoplasms; Drug Evaluation, Preclinical; Ellipticines; Humans; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
Molecular modeling of wild-type and D816V c-Kit inhibition based on ATP-competitive binding of ellipticine derivatives to tyrosine kinases.
Topics: Adenosine Triphosphate; Binding, Competitive; Ellipticines; Mutation; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit | 2005 |
Antiplasmodial activity of synthetic ellipticine derivatives and an isolated analog.
Topics: Animals; Antimalarials; Aspidosperma; Chloroquine; Disease Models, Animal; Ellipticines; Fibroblasts; Humans; Mice; Molecular Structure; Plant Bark; Plasmodium falciparum | 2014 |
Determination of binding modes and binding constants for the complexes of 6H-pyrido[4,3-b]carbazole derivatives with DNA.
Topics: Animals; Binding Sites; Carbazoles; Cell Survival; DNA; Dose-Response Relationship, Drug; HeLa Cells; Humans; Mice; Models, Molecular; Molecular Structure; NIH 3T3 Cells; Quartz Crystal Microbalance Techniques; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |
Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
Topics: Alkaloids; Animals; DNA; DNA Topoisomerases, Type II; Drug Carriers; Ellipticines; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etoposide; Fluorescence; Mice; Rats; Receptors, Opioid | 1989 |
Inhibition of p53 protein phosphorylation by 9-hydroxyellipticine: a possible anticancer mechanism.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Lewis Lung; CDC2-CDC28 Kinases; Cell Death; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Ellipticines; Enzyme Inhibitors; Histones; Humans; Mice; Mice, Inbred Strains; Microsomes; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties.
Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53 | 2015 |